# Serology vs. PCR in Veterinary Infectious Disease Diagnosis

## Quick Answer

- Choose PCR when you need to confirm an active infection, especially early in disease when clinical signs first appear and before antibodies have formed.
- Choose serology when you need evidence of past exposure, vaccination response, or population-level surveillance for chronic or endemic diseases.
- The main limitation is that serology cannot distinguish current infection from past exposure, while PCR may miss cases after the pathogen has been cleared from sampled tissues.

## Understanding the Diagnostic Question

Veterinarians face a practical decision when a patient presents with signs compatible with an infectious disease. The choice between serology and PCR changes what clinical question can be answered, how quickly results become actionable, and what limitations must be communicated to the client. Both test categories have legitimate roles in veterinary medicine, but they answer fundamentally different questions about the patient's infectious disease status.

Serology detects the host's immune response to a pathogen, typically through antibodies such as IgM and IgG. PCR detects the genetic material of the pathogen itself, confirming that the organism is present in the sampled tissue or fluid at the time of collection. The clinical utility of each approach depends on the timing of sampling relative to infection, the natural history of the disease, and the specific management decision that the test result will inform.

The American Veterinary Medical Association emphasizes that pet owners should maintain regular communication with their veterinarian about preventive care and health concerns. This relationship matters when diagnostic testing is needed because the veterinarian must interpret test results in the context of the individual patient's history, clinical signs, and risk factors. A positive PCR result for a pathogen does not always explain the patient's illness, and a negative serology result does not always rule out infection if sampling occurred before antibody development.

## Core Principles of Serologic Testing

Serologic tests measure antibodies produced by the host in response to infection or vaccination. The two main antibody classes relevant to veterinary diagnostics are IgM and IgG. IgM typically appears first during an acute infection and declines relatively quickly, while IgG appears slightly later and persists longer, often for months to years. This temporal pattern allows IgM to serve as a marker of recent or active infection in some diseases, while IgG indicates past exposure or vaccination.

The diagnostic window for serology is a critical concept. Antibodies take time to develop after initial infection, so sampling too early can produce a false negative result. A study of pertussis toxin IgG dynamics in humans demonstrated that antibody levels rise to a peak over approximately two weeks after symptomatic infection, with adults reaching peak levels later than children. While this study involved human patients, the underlying principle of antibody kinetics applies broadly to infectious disease diagnosis. The time required for a detectable antibody response means that serology is rarely useful in the first days of clinical illness.

IgM detection can shorten this window in some veterinary diseases. Research on cytauxzoonosis in cats found that anti-Cytauxzoon felis IgM antibodies were detectable at day 12 after tick infestation, within 24 hours of clinical signs developing. This IgM ELISA detected acute cytauxzoonosis in 94.44 percent of cats presenting with clinical signs, with 100 percent specificity at the higher cutoff. The same study showed that IgG appeared later, at day 15 post-infestation, confirming the expected IgM-to-IgG sequence. This example illustrates that species-specific and disease-specific serologic tests can provide clinically useful early diagnosis when the appropriate antibody class is targeted.

Serology has several inherent limitations that influence test interpretation. Antibody presence does not prove that the pathogen is currently present. A patient can have antibodies from a resolved infection months or years earlier. Vaccination also produces antibodies that are indistinguishable from infection-induced antibodies in many serologic tests. Cross-reactivity between related pathogens can produce false positive results. Finally, immunosuppressed patients may fail to mount a detectable antibody response despite active infection.

## Core Principles of PCR Testing

Polymerase chain reaction amplifies specific DNA or RNA sequences from the pathogen, allowing detection of minute quantities of genetic material in clinical samples. PCR confirms that the pathogen is present in the sample at the time of collection. This direct detection approach differs fundamentally from serology, which infers infection from the host's immune response.

The diagnostic window for PCR begins earlier than for serology. Pathogen genetic material is present from the onset of infection, before the host has produced detectable antibodies. This makes PCR the preferred test when clinical signs are recent and the veterinarian needs to confirm active infection quickly. PCR can also identify the specific pathogen species or strain, which is valuable when multiple related pathogens cause similar clinical signs.

PCR testing has important limitations. The pathogen must be present in the sampled tissue or fluid at the time of collection. Intermittent shedding or sequestration of the pathogen in tissues not sampled can produce false negative results. Contamination during sample collection or processing can produce false positive results. PCR also detects genetic material from dead organisms, so a positive result does not always prove the presence of viable, actively replicating pathogen.

Quantitative PCR adds another dimension by measuring the amount of pathogen genetic material in the sample. This can help distinguish active infection from low-level carriage or contamination. However, interpretation of quantitative results requires disease-specific knowledge because the clinical significance of a given cycle threshold value varies by pathogen and sample type.

## At a Glance

The following table summarizes the key differences between serology and PCR across the diagnostic timeline.

| Test Characteristic | Serology | PCR |
| --- | --- | --- |
| What is detected | Host antibodies (IgM, IgG) | Pathogen genetic material |
| Earliest positive result | Days to weeks after infection, depending on antibody class | Days after infection, often before clinical signs |
| Duration of positivity | Weeks to years, depending on antibody class and disease | Days to weeks, depending on pathogen clearance |
| Distinguishes active vs. past infection | IgM suggests recent infection, IgG alone does not distinguish | Positive result indicates pathogen presence at sampling |
| Effect of vaccination | Can produce positive results indistinguishable from infection | No effect, unless live vaccine strains are detected |
| Effect of immunosuppression | May cause false negatives | Generally unaffected |

The practical implication of these differences is that PCR is the test of choice for confirming active infection in an acutely ill patient, while serology is better suited for documenting exposure, monitoring vaccine response, or conducting population-level surveillance.

## Clinical Scenarios Favoring PCR

PCR is preferred when the clinical question requires confirmation that a pathogen is currently present in the patient. Several specific scenarios illustrate this principle.

### Acute Disease with Recent Onset

When a patient presents with acute clinical signs compatible with an infectious disease, PCR offers the best chance of early confirmation. The pathogen is likely present in high numbers in affected tissues or body fluids during the acute phase. Sampling at this time maximizes the sensitivity of PCR. Serology would likely be negative because antibodies have not yet developed.

The cytauxzoonosis research provides a concrete example. Cats with acute Cytauxzoon felis infection were identified as PCR-positive, and the IgM ELISA was developed using plasma samples from these confirmed cases. The study demonstrated that IgM became detectable at day 12 post-infestation, within 24 hours of clinical signs. This means that even the earliest serologic marker appears only after the infection is well established. PCR would have detected the pathogen earlier in the course of infection.

### Immunosuppressed Patients

Patients with compromised immune systems may not produce detectable antibodies even when actively infected. This includes animals receiving immunosuppressive drugs, animals with retroviral infections such as feline immunodeficiency virus or feline leukemia virus, and neonates with immature immune systems. In these patients, serology can produce false negative results despite active infection. PCR bypasses the host immune response entirely by detecting the pathogen directly.

### Distinguishing Pathogen Species or Strains

When multiple pathogens cause similar clinical signs, PCR can identify the specific organism involved. This is particularly important in respiratory disease complexes where viruses and bacteria produce overlapping clinical presentations. The avian metapneumovirus outbreak investigation in Pennsylvania demonstrated the value of PCR in identifying specific subtypes during an outbreak. The study reported that 169 cases were positive on PCR, 221 on ELISA, and 15 on both PCR and ELISA. PCR testing allowed identification of subtypes A and B, information that serology alone could not provide.

### Monitoring Response to Treatment

PCR can be used to monitor clearance of a pathogen after treatment. A negative PCR result after a course of antimicrobial or antiviral therapy suggests that the pathogen has been eliminated from the sampled site. Serology would remain positive for weeks to months after successful treatment because antibodies persist, making it useless for monitoring treatment response.

## Clinical Scenarios Favoring Serology

Serology is preferred when the clinical question involves past exposure, immune status, or population-level patterns of infection. Several scenarios illustrate when serology provides the most clinically relevant information.

### Documenting Past Exposure or Infection

When a veterinarian needs to know whether a patient has been exposed to a pathogen in the past, serology is the appropriate test. This is relevant for zoonotic diseases where the owner may have been exposed, for diseases with long incubation periods, and for conditions where infection may have been subclinical. A positive IgG result indicates that the patient encountered the pathogen or vaccine at some point, though it cannot pinpoint when the exposure occurred.

### Population Surveillance and Epidemiology

Serology is well suited for surveillance studies that assess the prevalence of infection in animal populations. The severe fever with thrombocytopenia syndrome virus study in wild boars in Japan illustrates this application. The researchers tested 1,506 serum samples by ELISA and found significantly higher seropositivity in Miyazaki Prefecture (34.1 percent) compared with Oita Prefecture (11.9 percent). This regional difference in seropositivity broadly corresponded with the distribution of human SFTS cases, suggesting that serologic surveillance in wildlife can serve as an indicator of regional transmission patterns.

The same study demonstrated an important limitation of serology in surveillance. While ELISA positivity differed significantly between the two prefectures, the plaque reduction neutralization test positivity rates and viral RNA detection rates did not reach statistical significance. This discrepancy highlights that different serologic methods can produce different results, and that seropositivity does not necessarily correlate with current viral presence.

### Assessing Vaccine Response

Serology can confirm that a patient has mounted an appropriate antibody response to vaccination. This is particularly relevant for diseases where vaccine efficacy is variable or where individual patients may not respond adequately. A positive antibody titer after vaccination provides evidence of immune response, though the correlation between antibody levels and protection varies by disease.

### Chronic or Persistent Infections

Some pathogens establish chronic infections where the organism is present at low levels or in protected sites. In these cases, PCR may be negative because the pathogen is not present in the sampled tissue at detectable levels. Serology may be the only positive test result, indicating that the patient has been infected even if the pathogen cannot be directly detected.

## Test Performance Characteristics

Sensitivity and specificity are fundamental concepts that guide test selection and interpretation. Sensitivity refers to the proportion of truly infected patients that test positive. Specificity refers to the proportion of truly uninfected patients that test negative. No test is perfect on either measure, and the balance between sensitivity and specificity affects clinical utility.

The cytauxzoonosis IgM ELISA study provides a concrete example of how cutoff values affect test performance. Using a higher cutoff of 19.85 percent positive, the test detected acute cytauxzoonosis in 94.44 percent of affected cats with 100 percent specificity. Using a lower cutoff of 8.60 percent positive, the test detected the two remaining PCR-positive cats but specificity dropped to 87.88 percent. This tradeoff between sensitivity and specificity is a fundamental feature of diagnostic testing. Choosing a lower cutoff catches more true positives but also produces more false positives.

PCR tests also have variable sensitivity and specificity depending on the target sequence, sample type, and assay design. Contamination is a particular concern because PCR amplifies even tiny amounts of genetic material. A single contaminated sample or reagent can produce false positive results across an entire run. Strict laboratory protocols and appropriate controls are essential for reliable PCR results.

The avian metapneumovirus outbreak data illustrate that PCR and ELISA can identify different subsets of infected flocks. Of the 405 positive Pennsylvania cases, 169 were positive on PCR only, 221 on ELISA only, and 15 on both tests. This pattern suggests that the two tests detect different stages or aspects of infection. Flocks tested early in the course of infection may be PCR-positive but ELISA-negative because antibodies have not yet developed. Flocks tested later may be PCR-negative because the virus has been cleared but ELISA-positive because antibodies persist.

## Practical Workflow for Test Selection

The following decision pathway can guide test selection when an infectious disease is suspected. This workflow assumes that the veterinarian has already performed a thorough clinical examination and has a differential diagnosis that includes specific infectious agents.

```mermaid
flowchart TD
    A[Patient presents with clinical signs] --> B{Is the pathogen likely present in accessible samples?}
    B -->|Yes| C[PCR preferred for confirmation]
    B -->|No| D[Serology may be only option]
    C --> E{How long since exposure or onset?}
    E -->|Days| F[PCR most sensitive]
    E -->|Weeks to months| G[Consider both PCR and serology]
    D --> H{Is the question about past exposure?}
    H -->|Yes| I[Serology for IgG]
    H -->|No| J[Consider other diagnostic approaches]
    F --> K[Interpret result with clinical context]
    G --> K
    I --> K
    J --> K
```

The first question is whether the pathogen is likely present in samples that can be collected from the patient. For respiratory pathogens, nasal or pharyngeal swabs may contain the organism during acute infection. For blood-borne pathogens, whole blood or serum may be appropriate. If the pathogen is likely present, PCR offers the advantage of direct detection.

The second question is the timing of sampling relative to exposure or onset of clinical signs. Early in the course of infection, PCR is more likely to be positive because the pathogen is present and antibodies have not yet developed. Later in the course, the pathogen may have been cleared while antibodies persist, making serology the more sensitive approach.

The third question is what clinical decision the test result will inform. If the decision is whether to start specific treatment, PCR confirmation of active infection is valuable. If the decision is whether a patient has been exposed to a zoonotic pathogen, serology provides the relevant information.

## Sample Collection and Handling

Sample quality directly affects test performance for both serology and PCR. Poor sample collection, improper storage, or delayed transport can produce false negative results regardless of the test method.

For serology, serum or plasma is typically required. Blood should be collected into appropriate tubes and allowed to clot before centrifugation. Hemolyzed or lipemic samples can interfere with some serologic assays. Samples should be refrigerated or frozen if testing will be delayed.

For PCR, the sample type depends on the pathogen and the clinical syndrome. Whole blood, serum, plasma, swabs from affected sites, tissue biopsies, and body fluids can all be used. The key requirement is that the sample must contain the pathogen if it is present in the patient. Sampling the wrong site can produce a false negative result even when the patient is infected.

Contamination is a particular concern for PCR. Collection devices, transport media, and laboratory reagents can all introduce contaminating genetic material. Samples should be collected with sterile equipment and transported in appropriate containers. The laboratory should include negative controls in every run to detect contamination.

The avian metapneumovirus outbreak investigation relied on samples submitted to the Pennsylvania Animal Diagnostic Laboratory System. The study reported that 883 cases requested aMPV PCR and/or ELISA testing during the study period, with 405 positive cases identified. This large-scale testing effort depended on consistent sample collection and submission practices across many veterinary practices and producers.

## Interpretation Challenges and Common Pitfalls

Several common pitfalls can lead to misinterpretation of serology and PCR results. Recognizing these patterns helps veterinarians avoid diagnostic errors.

### False Negative Serology in Acute Infection

The most common pitfall is sampling too early for serology. A patient in the first days of clinical illness may have no detectable antibodies because the immune response takes time to develop. A negative serology result at this stage does not rule out infection. If serology is the only test performed, the diagnosis may be missed.

### False Negative PCR Due to Sampling Error

PCR can produce false negative results when the pathogen is not present in the sampled tissue or fluid. This can occur with intermittent shedding, when the pathogen has localized to a site that was not sampled, or when the pathogen has been cleared from the sampled site. A negative PCR result does not rule out infection if the sample may not represent the site of infection.

### Positive Serology in Vaccinated Patients

Vaccination produces antibodies that are often indistinguishable from infection-induced antibodies in serologic tests. A positive serology result in a vaccinated patient does not prove natural infection. This is particularly relevant for diseases where vaccination is common, such as canine distemper, parvovirus, and feline respiratory viruses.

### Positive PCR from Dead Organisms

PCR detects genetic material from both viable and nonviable organisms. A positive PCR result does not prove that the patient has an active, replicating infection. This is relevant when the pathogen may have been killed by treatment but genetic material remains in the sample.

### Discordant PCR and Serology Results

The avian metapneumovirus data showed that PCR and ELISA can produce discordant results. Of the 405 positive cases, only 15 were positive on both tests. This means that relying on a single test would have missed many positive cases. When clinical suspicion is high and one test is negative, the other test may provide the diagnosis.

## Records and Documentation

Accurate records are essential for interpreting diagnostic test results and for tracking disease patterns over time. The following information should be documented for every serology or PCR test:

- Patient identification and signalment
- Date of sample collection
- Sample type and collection site
- Clinical signs and duration
- Vaccination history
- Recent treatment history
- Test method and laboratory
- Test result and interpretation
- Clinical decision based on the result

For herd or flock testing, records should include the number of animals tested, the number positive, and the sampling strategy. This information supports surveillance efforts and helps identify emerging disease patterns. The World Organisation for Animal Health emphasizes the importance of animal health surveillance and reporting for controlling infectious diseases. Accurate diagnostic records contribute to these efforts by providing data on disease occurrence and distribution.

## Common Failure Patterns in Diagnostic Testing

Several recurring problems can undermine the value of diagnostic testing. Recognizing these patterns helps veterinarians and producers avoid costly errors.

### Testing Too Early or Too Late

Sampling at the wrong time relative to infection is the most common cause of false negative results. Testing too early for serology misses the antibody response. Testing too late for PCR misses the pathogen after it has been cleared. Understanding the diagnostic window for each test and each disease is essential for selecting the appropriate sampling time.

### Using the Wrong Test for the Clinical Question

Serology cannot answer the question of active infection, and PCR cannot answer the question of past exposure. Using the wrong test for the clinical question produces results that are difficult to interpret and may lead to incorrect clinical decisions.

### Ignoring Vaccination History

Vaccination can produce positive serology results that are unrelated to natural infection. Failing to account for vaccination history can lead to misdiagnosis of diseases that are actually vaccine responses.

### Overinterpreting Single Test Results

A single positive or negative result rarely provides complete diagnostic certainty. Clinical signs, history, and other laboratory findings must be integrated with test results to reach a diagnosis. The avian metapneumovirus data showed that many positive cases were identified by only one of the two test methods, emphasizing the value of using multiple diagnostic approaches when appropriate.

### Poor Sample Quality

Samples that are hemolyzed, contaminated, degraded, or collected from the wrong site can produce unreliable results. Investing in proper sample collection and handling improves the value of diagnostic testing.

## Welfare and Safety Considerations

Diagnostic testing has welfare implications for individual animals and population-level implications for disease control. The American Veterinary Medical Association emphasizes the importance of preventive care and regular veterinary engagement for pet health. Diagnostic testing is part of this preventive approach when it identifies infections early and guides appropriate treatment.

For individual patients, the welfare benefit of accurate diagnosis is clear. Early identification of a treatable infection allows prompt treatment and reduces suffering. The cytauxzoonosis research noted that early diagnosis and therapeutic intervention are crucial to survival of infected cats. This principle applies broadly across veterinary infectious diseases.

For populations, diagnostic testing supports disease surveillance and control. The World Organisation for Animal Health promotes animal health surveillance as a core activity for preventing and controlling infectious diseases. Serologic surveillance in wildlife, as demonstrated in the severe fever with thrombocytopenia syndrome virus study, can identify regional transmission patterns and inform public health responses.

Safety considerations include the zoonotic potential of some pathogens. The tick-borne disease review emphasized the One Health concept, noting that human health and animal health are closely linked through shared tick-borne pathogens. Animals can serve as reservoirs or sentinel hosts for zoonotic diseases. Accurate veterinary diagnosis of these pathogens protects both animal and human health.

## Professional Escalation Criteria

Veterinarians should escalate diagnostic decisions to a specialist or reference laboratory in several situations:

- When the clinical presentation is unusual or severe and the diagnosis remains unclear after initial testing
- When test results are discordant with clinical signs or with each other
- When specialized testing is needed that is not available at the primary laboratory
- When a zoonotic disease is suspected and public health involvement may be needed
- When a notifiable disease is suspected and official reporting is required
- When herd or flock outbreaks involve multiple animals and epidemiologic investigation is warranted

The World Organisation for Animal Health provides guidance on notifiable diseases and reporting requirements. Veterinarians should be familiar with the reporting requirements in their jurisdiction and should contact the appropriate authorities when a notifiable disease is suspected.

## Cost and Turnaround Time Considerations

Cost and turnaround time are practical factors that influence test selection. PCR is generally more expensive than serology and may require specialized laboratory equipment and trained personnel. Serology is often less expensive and may be available through commercial laboratories with rapid turnaround.

The clinical urgency of the situation should guide the balance between cost and speed. For a critically ill patient where treatment decisions depend on the test result, the additional cost of PCR may be justified by the faster and more definitive result. For surveillance testing where the goal is to assess population-level exposure, the lower cost of serology may allow testing of more animals.

The avian metapneumovirus outbreak investigation demonstrated the value of large-scale testing during an outbreak. The Pennsylvania Animal Diagnostic Laboratory System processed 883 cases requesting aMPV testing over a one-year period. This level of testing requires laboratory capacity and resources that may not be available in all settings.

## Comparative Decision Table for Common Clinical Scenarios

The following table provides a practical reference for test selection across common clinical scenarios encountered in veterinary practice.

| Clinical Scenario | Preferred Test | Rationale | Key Limitation |
| --- | --- | --- | --- |
| Acute respiratory signs with recent onset | PCR | Pathogen present in respiratory samples before antibodies develop | May be negative if sampling occurs after viral clearance |
| Suspected tick-borne disease with fever | PCR or IgM serology | Both can detect early infection, IgM appears within days of clinical signs | PCR may miss low-level parasitemia, IgM requires species-specific assay |
| Herd or flock exposure assessment | Serology (ELISA) | Detects past exposure across populations at lower cost per animal | Cannot distinguish recent from historical exposure |
| Monitoring treatment efficacy | PCR | Negative result after therapy indicates pathogen clearance | Positive result may reflect dead organisms, not active infection |
| Vaccination response evaluation | Serology (IgG titer) | Measures humoral immune response to vaccine | Antibody levels do not always correlate with protection |
| Zoonotic disease exposure inquiry | Serology | Documents past exposure relevant to human health risk | Cannot confirm active shedding or current infectivity |

## Building a Diagnostic Decision Log for Serology and PCR Selection

A structured decision log transforms test selection from an improvised choice into a repeatable clinical process. When veterinarians face recurring cases with similar presentations, a written record of test choices, results, and outcomes reveals patterns that improve future decisions. This section provides a practical framework for building and maintaining such a log, with specific fields, review triggers, and troubleshooting steps tailored to serology and PCR selection.

### Why a Decision Log Matters

The avian metapneumovirus outbreak data from Pennsylvania illustrates why systematic documentation matters. Of 883 cases requesting aMPV PCR and/or ELISA testing, 405 were positive, but only 15 were positive on both tests. Without a decision log, a practice might conclude that PCR is superior because it detected 169 cases, or that ELISA is superior because it detected 221 cases. Neither conclusion captures the full picture. A decision log that records which test was chosen, why it was chosen, and what the result was allows a practice to see that both tests identify different subsets of infected flocks and that test selection depends on disease stage.

The same principle applies to individual patients. A veterinarian who records the clinical question, the test selected, and the outcome builds a personal evidence base that complements published literature. Over time, patterns emerge. For example, a practice may notice that PCR for a particular respiratory pathogen is consistently negative in patients presenting more than five days after clinical signs begin, while serology is consistently positive. This observation refines future test selection.

### Core Fields for the Decision Log

The decision log should capture enough information to answer three questions after the fact. First, what was the clinical question? Second, why was a particular test chosen? Third, did the test result change the clinical outcome? The following fields support these questions.

Patient identification and signalment should be recorded for every entry. Species, breed, age, sex, and vaccination status provide context for interpreting results. A vaccinated patient with a positive serology result has a different clinical meaning than an unvaccinated patient with the same result.

The clinical question should be written explicitly. Examples include confirming active infection in an acutely ill patient, ruling out infection in a patient with compatible signs, documenting past exposure for zoonotic risk assessment, monitoring treatment response, or assessing vaccine response. Writing the question explicitly prevents the common error of ordering a test without a clear decision in mind.

The test selection rationale should record the factors that influenced the choice. These include the timing of sampling relative to clinical sign onset, the suspected pathogen, the sample types available, the patient's immune status, vaccination history, cost considerations, and turnaround time requirements. Recording the rationale makes the decision process visible and reviewable.

The test results should include the specific test method, the laboratory, the numerical result or titer where applicable, and the laboratory's reference range or interpretation. Raw results matter more than a simple positive or negative designation because cutoff values affect interpretation. The cytauxzoonosis IgM ELISA study demonstrated this clearly. Using a higher cutoff of 19.85 percent positive detected 94.44 percent of affected cats with 100 percent specificity. Using a lower cutoff of 8.60 percent positive detected the remaining two PCR-positive cats but dropped specificity to 87.88 percent. A decision log that records only positive or negative loses this nuance.

The clinical interpretation should state what the result meant in the context of the patient's presentation. This includes whether the result confirmed or ruled out the suspected diagnosis, whether it changed the treatment plan, and whether additional testing was recommended.

The outcome field records what happened after the test result was obtained. This includes the treatment administered, the patient's response, and any follow-up testing. Outcome data are essential for evaluating whether the test selection was clinically useful.

### Building the Log into Practice Workflow

The decision log should be integrated into the existing medical record system instead of maintained as a separate document. This reduces the burden of data entry and ensures that the log is updated consistently. A standardized template within the practice management software works well. The template should include the fields described above as structured data entry points instead of free text where possible.

Structured data entry enables later analysis. If the practice management system records the clinical question as a selectable category, the veterinarian can later query the system for all cases where the clinical question was confirming active infection and review which tests were selected and how often they produced actionable results. Free text entries are harder to analyze systematically.

The log should be reviewed at regular intervals. A quarterly review is appropriate for most practices. The review should identify cases where the test result did not change clinical management, cases where discordant results required additional testing, and cases where the initial test choice proved to be incorrect in retrospect. These cases are the most valuable learning opportunities.

### Review Triggers and Escalation Criteria

The decision log should include a field for flagging cases that require review or escalation. The following situations warrant a flag.

Discordant results between PCR and serology should always be flagged. The avian metapneumovirus data showed that discordant results are common. Of 405 positive cases, only 15 were positive on both tests. When PCR and serology disagree, the veterinarian should document the likely explanation. Early infection produces PCR-positive, serology-negative results. Late infection produces PCR-negative, serology-positive results. Vaccination can produce serology-positive results without infection. Immunosuppression can produce PCR-positive, serology-negative results because the host fails to mount an antibody response.

Unexpected results should be flagged for review. An unexpected result is one that contradicts the clinical picture or the pretest probability of disease. For example, a positive PCR result in a patient with no clinical signs or known exposure warrants review. A negative serology result in a patient with classic clinical signs and known exposure also warrants review.

Results that do not change clinical management should be flagged. If the test result did not influence the treatment decision, the test may have been unnecessary or the wrong test may have been selected. This does not mean the test was worthless. A negative result can be valuable for ruling out a differential diagnosis. However, if the result was ignored or overridden by clinical judgment, the test selection should be reviewed.

Cases involving zoonotic pathogens should be flagged for public health consideration. The tick-borne disease review emphasized the One Health concept, noting that animals can serve as reservoirs or sentinel hosts for zoonotic pathogens. When a zoonotic disease is suspected or confirmed, the decision log should document whether the appropriate public health authorities were notified and whether the owner received appropriate counseling about human health risks.

### Troubleshooting Recurring Problems

The decision log enables systematic troubleshooting of recurring diagnostic problems. The following approach addresses common patterns that emerge from log review.

If the log shows a high rate of negative PCR results in patients with strong clinical suspicion of infection, the first question is whether sampling occurred at the right time and from the right site. PCR detects pathogen genetic material only if the pathogen is present in the sampled tissue or fluid at the time of collection. Intermittent shedding and pathogen sequestration in unsampled tissues produce false negative results. The log should record the sample type and collection site so this can be reviewed.

If the log shows a high rate of positive serology results that do not correlate with clinical disease, the first question is whether vaccination is producing antibodies that are indistinguishable from infection-induced antibodies. The log should record vaccination history for every patient. If vaccination is the likely explanation, the test selection rationale should reflect this and the interpretation should note that the positive result does not confirm natural infection.

If the log shows frequent discordant PCR and serology results, the practice should review the timing of sampling relative to clinical sign onset. The diagnostic windows for PCR and serology differ. PCR is positive early in infection when the pathogen is present and antibodies have not yet developed. Serology is positive later when antibodies have formed and the pathogen may have been cleared. The pertussis toxin IgG study in humans demonstrated that antibody levels rise to a peak over approximately two weeks after symptomatic infection. While this study involved human patients, the principle of antibody kinetics applies broadly. Sampling too early for serology produces false negative results. Sampling too late for PCR produces false negative results.

If the log shows that test results frequently do not change clinical management, the practice should review whether the clinical question was clearly defined before testing. The most common error is ordering a test without specifying what decision the result will inform. The decision log enforces clarity by requiring the clinical question to be written explicitly.

### Sample Decision Log Template

The following template can be adapted to a practice management system or paper record.

| Field | Entry |
| --- | --- |
| Date | Date of sample collection |
| Patient ID | Unique identifier |
| Species and breed | Species, breed, age, sex |
| Vaccination status | Dates and types of relevant vaccines |
| Clinical question | Confirm active infection, rule out infection, document exposure, monitor treatment, assess vaccine response |
| Clinical signs and duration | Description and onset date |
| Suspected pathogen | Differential diagnosis |
| Test selected | PCR, serology, or both |
| Test rationale | Timing, immune status, sample availability, cost, urgency |
| Sample type and site | Blood, swab, tissue, fluid and specific location |
| Laboratory and test method | Laboratory name and specific assay |
| Result | Numerical value or titer and reference range |
| Interpretation | Clinical meaning in context |
| Clinical decision | Treatment, additional testing, monitoring, no change |
| Outcome | Patient response and follow-up |
| Flag for review | Yes or no and reason |

### Using the Log for Population-Level Decisions

The decision log also supports population-level decisions in herd and flock practice. When multiple animals are tested, the log should record the sampling strategy, the number tested, the number positive, and the test method. This information supports surveillance efforts and helps identify emerging disease patterns.

The severe fever with thrombocytopenia syndrome virus study in wild boars in Japan provides an example of population-level serologic surveillance. The researchers tested 1,506 serum samples by ELISA and found significantly higher seropositivity in Miyazaki Prefecture at 34.1 percent compared with Oita Prefecture at 11.9 percent. This regional difference corresponded broadly with the distribution of human SFTS cases. A practice that maintains a decision log for herd or flock testing can identify similar patterns over time, such as increasing seropositivity in a region or a higher rate of PCR positivity in one production type compared with another.

The avian metapneumovirus outbreak investigation demonstrated the value of production-type data. The greatest numbers of positive cases were associated with commercial turkey flocks at 42 percent, followed by commercial layer flocks at 27 percent, broiler breeder flocks at 17 percent, commercial broiler flocks at 13 percent, and layer breeder flocks at 3 percent. A decision log that records production type for each submission allows a practice or diagnostic laboratory to identify which production types are most affected and to target surveillance efforts accordingly.

The same study found an average of 2.4 co-infections per aMPV-positive necropsy case. Escherichia coli was the most common co-infection across all production types. In chickens, Avibacterium paragallinarum, Gallibacterium anatis, and infectious bronchitis virus were common co-infections. In commercial turkeys, Ornithobacterium rhinotracheale was common. A decision log that records co-infections helps veterinarians anticipate which secondary pathogens are likely to complicate a primary viral infection and guides treatment decisions.

### Limitations of the Decision Log

The decision log has limitations that should be acknowledged. It captures only cases that were tested, not cases where testing was considered and declined. This selection bias can distort patterns. For example, if a practice rarely tests patients with mild clinical signs, the log will overrepresent severe cases and may suggest that a particular test is more sensitive than it actually is.

The log also depends on accurate and complete data entry. Missing vaccination history, unclear clinical questions, and incomplete outcome data reduce the value of the log. Practices should designate responsibility for log maintenance and review data completeness at regular intervals.

Finally, the log reflects the experience of a single practice or veterinarian. Patterns observed in one practice may not generalize to other settings with different patient populations, pathogens, and laboratory capabilities. The log should complement, not replace, published literature and consultation with specialists.

### Professional Escalation Criteria for Diagnostic Decisions

The decision log should include a field for flagging cases that warrant escalation to a specialist or reference laboratory. The following criteria indicate when escalation is appropriate.

When the diagnosis remains unclear after initial testing and the patient's condition is deteriorating, escalation is warranted. This includes cases where PCR and serology are discordant and the clinical picture does not clearly favor one result over the other.

When specialized testing is needed that is not available at the primary laboratory, escalation is warranted. This includes plaque reduction neutralization testing, which the severe fever with thrombocytopenia syndrome virus study used to confirm ELISA results. The study found that PRNT80 positivity rates were higher in Miyazaki at 44.2 percent compared with Oita at 37.0 percent, but the difference did not reach statistical significance. This illustrates that confirmatory testing can provide different information than screening tests and may require specialized laboratory capacity.

When a zoonotic disease is suspected and public health involvement may be needed, escalation is warranted. The tick-borne disease review emphasized that animals can serve as reservoirs or sentinel hosts for zoonotic pathogens. Veterinarians should be familiar with the reporting requirements in their jurisdiction and should contact the appropriate authorities when a zoonotic or notifiable disease is suspected.

When a herd or flock outbreak involves multiple animals and epidemiologic investigation is warranted, escalation is warranted. The avian metapneumovirus outbreak investigation involved 405 positive cases across multiple production types over a one-year period. This level of investigation requires coordination between veterinary practices, diagnostic laboratories, and animal health authorities.

The World Organisation for Animal Health provides guidance on animal health surveillance and reporting. Veterinarians should be familiar with the reporting requirements in their jurisdiction and should document escalation decisions in the decision log.

## Frequently Asked Questions

### Can serology and PCR be used together in the same patient?

Yes, using both tests can provide complementary information. PCR can confirm active infection early in the disease course, while serology can document the immune response and provide evidence of infection if PCR is negative due to sampling timing or location. The avian metapneumovirus data showed that some cases were positive on only one test, suggesting that using both tests identifies more infected animals than either test alone.

### How long after infection does PCR remain positive?

The duration of PCR positivity depends on the pathogen and the sample type. Some pathogens are cleared quickly, while others persist for weeks or longer. PCR detects genetic material from both viable and nonviable organisms, so a positive result can persist after the pathogen has been killed by treatment or the immune response.

### How long after infection do antibodies remain detectable?

Antibody persistence varies by disease and by antibody class. IgM typically declines within weeks to months, while IgG can persist for months to years. The pertussis toxin IgG study in humans found that antibody half-life differed between adults and children, with adults having a shorter half-life of 24 days compared with 364 days in children. This illustrates that antibody dynamics are complex and disease-specific.

### Can vaccination cause a positive PCR result?

Vaccination does not typically cause positive PCR results because most vaccines do not contain live pathogen genetic material. However, live attenuated vaccines can produce positive PCR results if the vaccine strain is detected by the assay. This is more likely when PCR is performed shortly after vaccination.

### What does a positive IgM result mean?

A positive IgM result suggests recent infection because IgM is the first antibody class produced in response to infection. The cytauxzoonosis study found that IgM was detectable at day 12 post-infestation, within 24 hours of clinical signs. However, IgM can persist for variable periods, and some chronic infections may produce intermittent or persistent IgM.

### What does a positive IgG result mean?

A positive IgG result indicates that the patient has been exposed to the pathogen or vaccine at some point in the past. IgG alone does not distinguish between current and past infection. The cytauxzoonosis study found that chronic carriers had variable IgM and IgG results, and one febrile cat that was negative for Cytauxzoon felis had high IgG, illustrating that IgG results must be interpreted with clinical context.

### Why would PCR and serology results disagree?

Discordant results occur because the two tests measure different things at different times. PCR detects the pathogen directly and is positive during active infection. Serology detects the host immune response and becomes positive later. A patient tested early in infection may be PCR-positive and serology-negative. A patient tested later may be PCR-negative and serology-positive. The avian metapneumovirus data showed that only 15 of 405 positive cases were positive on both tests.

### When should I consult a specialist about diagnostic testing?

Consult a specialist when the diagnosis remains unclear after initial testing, when test results are discordant with clinical signs, when specialized testing is needed, when a zoonotic or notifiable disease is suspected, or when a herd or flock outbreak requires epidemiologic investigation. The World Organisation for Animal Health provides guidance on disease reporting and surveillance that can help determine when specialist consultation is appropriate.

## Related Veterinary Guides

- [Serology and Molecular Diagnostics in Infectious Disease](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/serology-and-molecular-diagnostics-in-infectious-disease)
- [Bovine Respiratory Disease Vaccine Selection: A Comparative Guide](/knowledge/veterinary-medicine/food-animal-medicine/bovine-respiratory-disease-vaccine-selection)
- [Veterinary Anatomy Book Selection: A Comparative Guide for NAVLE](/knowledge/veterinary-medicine/navle-exam-prep/veterinary-anatomy-book-selection-a-comparative-guide-for-navle)
- [Hematologic and Biochemical Changes in Infectious Diseases](/knowledge/veterinary-medicine/clinical-pathology/hematologic-biochemical-changes-infectious)
- [Interpreting Diagnostic Test Results in NAVLE Scenarios](/knowledge/veterinary-medicine/navle-exam-prep/interpreting-diagnostic-test-results-in-navle-scenarios)

## References and Further Reading

- [Pet Care](https://www.avma.org/resources-tools/pet-owners). American Veterinary Medical Association.
- [AAHA Guidelines](https://www.aaha.org/resources). American Animal Hospital Association.
- [Global Guidelines](https://wsava.org/global-guidelines). World Small Animal Veterinary Association.
- [Merck Veterinary Manual](https://www.merckvetmanual.com/). Merck Veterinary Manual.
- [Cornell University College of Veterinary Medicine](https://www.vet.cornell.edu/). Cornell University.
- [Animal Health and Welfare](https://www.woah.org/en/what-we-do/animal-health-and-welfare). World Organisation for Animal Health.
- [Tick-borne zoonoses and commonly used diagnostic methods in human and veterinary medicine.](https://pubmed.ncbi.nlm.nih.gov/33459849). Parasitology research, 2021.
- [A Serodiagnostic IgM ELISA to Detect Acute Cytauxzoonosis.](https://pubmed.ncbi.nlm.nih.gov/36297239). Pathogens (Basel, Switzerland), 2022.
- [Serological and molecular assessment of severe fever with thrombocytopenia syndrome virus infection in wild boars from two adjacent endemic prefectures in Japan.](https://pubmed.ncbi.nlm.nih.gov/42178278). The Journal of veterinary medical science, 2026.
- [Dynamics of pertussis toxin IgG after symptomatic pertussis in children and adults.](https://pubmed.ncbi.nlm.nih.gov/32171577). Vaccine, 2020.
- [Overview of Avian Metapneumovirus Outbreak in Pennsylvania.](https://pubmed.ncbi.nlm.nih.gov/41739615). Avian diseases, 2026.

> This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.